Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1480 participants
INTERVENTIONAL
2014-10-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main purpose of this study is to investigate whether "Medisinstart" increases patients' adherence to the prescribed medication. Patients' beliefs about their medicines and their motivation for adherence will also be examined. The study also aims at revealing if "Medisinstart" has additional benefits for the patient, the society and the pharmacies.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Medisinstart for Type 2 Diabetes
NCT06273657
Implementation of a New Model of Care for Supporting Long-term Medication Adherence (Phase A)
NCT06191835
Supporting Patients Starting New Medicines: Evaluating the myCare Start Service in Switzerland
NCT07036471
The Pharmacist Follows You and Your Medication From Hospital to Your Daily Life and Investigate What This Means to You
NCT03079375
Effect of Pharmacist Provided Drug Information Services After Hospital Discharge
NCT03829995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Medisinstart
Patients in this arm will receive the service; Medisinstart
Medisinstart
"Medisinstart" is a newly developed pharmacy service for patients about to start a new medicine for a chronic or long-term condition. It consists of two follow-up consultations with a pharmacist. The first at 1-2 weeks and the second at 3-5 weeks after start of the new medicine.
Current Practice
Patients in this arm will receive the current pharmacy practice of advice and guidance with their new medicine. This involves dispensing the medicine and briefly providing information regarding its use and potential side-effects.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medisinstart
"Medisinstart" is a newly developed pharmacy service for patients about to start a new medicine for a chronic or long-term condition. It consists of two follow-up consultations with a pharmacist. The first at 1-2 weeks and the second at 3-5 weeks after start of the new medicine.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dabigatran etexilate (B01AE07)
* Rivaroxaban (B01AF01)
* Apixaban (B01AF02)
* Beta blocking agents (C07)
* Calcium channel blockers (C08)
* Agents acting on the renin-angiotensin system (C09)
* HMG CoA reductase inhibitors (statins) (C10AA)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Pharmacy Association
OTHER
Apokus AS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karine W Ruud, PhD
Role: STUDY_DIRECTOR
Apokus AS
Sara Bremer, PhD
Role: STUDY_DIRECTOR
Apokus AS
Ragnar Hovland, PhD
Role: STUDY_DIRECTOR
Photocure ASA (current affiliation), Apokus AS (until Dec. 2016)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Apotek 1 Alta
Alta, , Norway
Apotek 1 Andselv
Andselv, , Norway
Boots apotek Harebakken
Arendal, , Norway
Sykehusapoteket Arendal
Arendal, , Norway
Boots apotek Moa
Ålesund, , Norway
Vitusapotek Raumnes
Årnes, , Norway
Vitusapotek Årnes
Årnes, , Norway
Apotek 1 Horisont
Bergen, , Norway
Boots apotek Bryggen
Bergen, , Norway
Sjukehusapoteket i Bergen
Bergen, , Norway
Sykehusapoteket i Bodø
Bodø, , Norway
Apotek 1 Brandbu
Brandbu, , Norway
Apotek 1 Bømlo
Bremnes, , Norway
Apotek 1 Åssiden
Drammen, , Norway
Sykehusapoteket Drammen
Drammen, , Norway
Boots apotek Elverum
Elverum, , Norway
Sykehusapoteket Elverum
Elverum, , Norway
Boots apotek Flisa
Flisa, , Norway
Apotek 1 Helsehuset Fredrikstad
Fredrikstad, , Norway
Sjukehusapoteket i Førde
Førde, , Norway
Boots apotek Hamar
Hamar, , Norway
Sjukehusapoteket i Haugesund
Haugesund, , Norway
Apotek 1 Lerka
Kleppe, , Norway
Apotek 1 Kopervik
Kopervik, , Norway
Vitusapotek Sørlandssenteret
Kristiansand, , Norway
Boots apotek Larvik
Larvik, , Norway
Apotek 1 Lofotsenteret
Leknes, , Norway
Apotek 1 Malvik
Malvik, , Norway
Apotek 1 Mandal
Mandal, , Norway
Ditt apotek Maura
Maura, , Norway
Ditt apotek Meyer
Mo i Rana, , Norway
Ditt apotek Ytteren
Mo i Rana, , Norway
Apotek 1 Sjøsiden
Mosjøen, , Norway
Vitusapotek Varnaveien Moss
Moss, , Norway
Apotek 1 Morenen
Mysen, , Norway
Vitusapotek Nesbru
Nesbru, , Norway
Apotek 1 St. Hanshaugen senter
Oslo, , Norway
Boots apotek Bogstadveien
Oslo, , Norway
Boots apotek Skøyen
Oslo, , Norway
Boots apotek Solli
Oslo, , Norway
Diakonhjemmets sykehusapotek
Oslo, , Norway
Lovisenberg sykehusapotek
Oslo, , Norway
Sykehusapoteket Oslo, Ullevål
Oslo, , Norway
Vitusapotek Storo
Oslo, , Norway
Vitusapotek Raufoss
Raufoss, , Norway
Apotek 1 Kvadrat
Sandnes, , Norway
Vitusapotek Ganddal
Sandnes, , Norway
Vitusapotek Syv Søstre
Sandnessjøen, , Norway
Apotek 1 Sandvika Storsenter
Sandvika, , Norway
Sykehusapoteket Bærum
Sandvika, , Norway
Boots apotek Lande
Sarpsborg, , Norway
Boots apotek Saupstad
Saupstad, , Norway
Vitusapotek Selbak
Sellebakk, , Norway
Apotek 1 Ski Amfi
Ski, , Norway
Sykehusapoteket Skien
Skien, , Norway
Apotek 1 Hjorten Stavanger
Stavanger, , Norway
Sjukehusapoteket i Stavanger
Stavanger, , Norway
Vitusapotek Løven Stavanger
Stavanger, , Norway
Vitusapotek Medisinsk senter - Steinkjer
Steinkjer, , Norway
Sykehusapoteket Lørenskog
Strømmen, , Norway
Vitusapotek Strømmen storsenter
Strømmen, , Norway
Vitusapotek K1 Tromsø
Tromsø, , Norway
Boots apotek Nordre
Trondheim, , Norway
Vitusapotek Solsiden
Trondheim, , Norway
Sykehusapoteket Tønsberg
Tønsberg, , Norway
Vitusapotek Innherred
Verdal, , Norway
Gausdal apotek
Østre Gausdal, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients' problems with new medication for chronic conditions. Qual Saf Health Care. 2004 Jun;13(3):172-5. doi: 10.1136/qhc.13.3.172.
Boyd M, Waring J, Barber N, Mehta R, Chuter A, Avery AJ, Salema NE, Davies J, Latif A, Tanajewski L, Elliott RA. Protocol for the New Medicine Service Study: a randomized controlled trial and economic evaluation with qualitative appraisal comparing the effectiveness and cost effectiveness of the New Medicine Service in community pharmacies in England. Trials. 2013 Dec 1;14:411. doi: 10.1186/1745-6215-14-411.
Clifford S, Barber N, Elliott R, Hartley E, Horne R. Patient-centred advice is effective in improving adherence to medicines. Pharm World Sci. 2006 Jun;28(3):165-70. doi: 10.1007/s11096-006-9026-6. Epub 2006 Sep 27.
Elliott RA, Barber N, Clifford S, Horne R, Hartley E. The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines. Pharm World Sci. 2008 Jan;30(1):17-23. doi: 10.1007/s11096-007-9134-y. Epub 2007 Jun 8.
Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002;(2):CD000011. doi: 10.1002/14651858.CD000011.
Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999 Dec;47(6):555-67. doi: 10.1016/s0022-3999(99)00057-4.
Hov I, Bjartnes M, Slordal L, Spigset O. [Are drugs taken as prescribed?]. Tidsskr Nor Laegeforen. 2012 Feb 21;132(4):418-22. doi: 10.4045/tidsskr.11.0225. Norwegian.
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008 May;10(5):348-54. doi: 10.1111/j.1751-7176.2008.07572.x.
Ruths S, Viktil KK, Blix HS. [Classification of drug-related problems]. Tidsskr Nor Laegeforen. 2007 Nov 29;127(23):3073-6. Norwegian.
Sabate E. (Ed.) (2003), Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Apokus-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.